Ultralife (FRA:ULB) Cyclically Adjusted Revenue per Share: €7.42 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ULB Ultralife Corp FRA:ULB
67 GF Score
Price €4.58
GF Value €7.84
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Ultralife Cyclically Adjusted Revenue per Share?

Ultralife FRA:ULB -2.55% 67 Cyclically Adjusted Revenue per Share is €7.42 as of Mar. 2026. GuruFocus rates FRA:ULB with a GF Score™ of 67/100 and a GF Value™ of €7.84 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ultralife's adjusted revenue per share for the three months ended in Mar. 2026 was €2.464. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €7.42 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ultralife's average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ultralife was 19.70% per year. The lowest was -8.40% per year. And the median was 7.30% per year.

As of today (2026-07-26), Ultralife's current stock price is €4.58. Ultralife's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €7.42. Ultralife's Cyclically Adjusted PS Ratio of today is 0.62.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ultralife was 1.71. The lowest was 0.47. And the median was 0.98.


Ultralife  (FRA:ULB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ultralife's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.58/7.42
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ultralife was 1.71. The lowest was 0.47. And the median was 0.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ultralife Cyclically Adjusted Revenue per Share Related Terms


Ultralife Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ultralife's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultralife Cyclically Adjusted Revenue per Share Chart

Ultralife Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.32 5.94 6.60 7.23 7.07

Ultralife Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.44 6.55 7.00 7.07 7.42

FRA:ULB vs NMAD, TGEN, APWC: Cyclically Adjusted Revenue per Share Comparison

For the Electrical Equipment & Parts subindustry, Ultralife's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultralife Cyclically Adjusted PS Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Ultralife's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ultralife's Cyclically Adjusted PS Ratio falls into.


FRA:ULB
67GF Score
Ultralife Corp FRA:ULB
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ultralife Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ultralife's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.464/330.2130*330.2130
=2.464

Current CPI (Mar. 2026) = 330.2130.

Ultralife Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.176 241.018 1.611
201609 1.143 241.428 1.563
201612 1.341 241.432 1.834
201703 1.316 243.801 1.782
201706 1.120 244.955 1.510
201709 1.106 246.819 1.480
201712 1.190 246.524 1.594
201803 1.155 249.554 1.528
201806 1.185 251.989 1.553
201809 1.054 252.439 1.379
201812 1.138 251.233 1.496
201903 1.030 254.202 1.338
201906 1.607 256.143 2.072
201909 1.545 256.759 1.987
201912 1.713 256.974 2.201
202003 1.452 258.115 1.858
202006 1.572 257.797 2.014
202009 1.286 260.280 1.632
202012 1.482 260.474 1.879
202103 1.351 264.877 1.684
202106 1.366 271.696 1.660
202109 1.151 274.310 1.386
202112 1.307 278.802 1.548
202203 1.713 287.504 1.967
202206 1.882 296.311 2.097
202209 2.081 296.808 2.315
202212 2.113 296.797 2.351
202303 1.848 301.836 2.022
202306 2.441 305.109 2.642
202309 2.270 307.789 2.435
202312 2.494 306.746 2.685
202403 2.335 312.332 2.469
202406 2.373 314.175 2.494
202409 1.906 315.301 1.996
202412 2.487 315.605 2.602
202503 2.814 319.799 2.906
202506 2.528 322.561 2.588
202509 2.220 324.800 2.257
202512 2.486 324.054 2.533
202603 2.464 330.213 2.464

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €7.42 mean?
Ultralife (FRA:ULB) has a Cyclically Adjusted Revenue per Share of €7.42 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ultralife and its competitors.
Is Ultralife's Cyclically Adjusted Revenue per Share too high?
Ultralife's current Cyclically Adjusted Revenue per Share is €7.42. Overall, Ultralife has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ultralife's Cyclically Adjusted Revenue per Share compare to NMAD and TGEN?
Ultralife's Cyclically Adjusted Revenue per Share of €7.42 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Industrial Products company?
A good Cyclically Adjusted Revenue per Share depends on the Industrial Products industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ultralife and its competitors. Ultralife's current Cyclically Adjusted Revenue per Share is €7.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultralife stock overvalued right now?
Based on GuruFocus' analysis, Ultralife (FRA:ULB) is currently considered Possible Value Trap. The stock's GF Value™ is €7.84, compared to a current price of €4.58 — trading 41.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €7.42. Ultralife's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ultralife (FRA:ULB), the current Cyclically Adjusted Revenue per Share is €7.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ultralife (FRA:ULB) Overvalued in 2026?

Based on GuruFocus' analysis, Ultralife stock appears to be undervalued. The current stock price of €4.58 is trading 41.6% below its estimated GF Value™ of €7.84. GuruFocus considers Ultralife to be Possible Value Trap.

Key valuation signals for FRA:ULB:

  • Cyclically Adjusted Revenue per Share: €7.42
  • GF Value™: €7.84 vs. price of €4.58 (41.6% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the FRA:ULB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ultralife Business Description

Other Exchanges ULBI:USAULB:Germany
Address 2000 Technology Parkway, Newark, NY, USA, 14513
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
67GF Score

Get the complete analysis for FRA:ULB

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.58
Price
€7.84
GF Value